NUAKs facilitate mTOR-mediated NSCLC proliferation and metastasis by modulating glucose metabolism and inhibiting p53 activity
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.NUAK1 and NUAK2 promote non-small cell lung cancer (NSCLC) growth by altering glucose metabolism. Inhibiting these proteins may offer a new therapeutic strategy for NSCLC treatment.
Area Of Science
- Oncology
- Molecular Biology
- Cancer Metabolism
Background
- Non-small cell lung cancer (NSCLC) exhibits altered glucose metabolism, including increased aerobic glycolysis and pentose phosphate pathway (PPP) activity.
- The precise mechanisms driving these metabolic changes and their role in NSCLC progression are not fully understood.
Purpose Of The Study
- To investigate the role of NUAK1 and NUAK2 in regulating glucose metabolism and tumorigenesis in NSCLC.
- To elucidate the molecular mechanisms by which NUAK1/2 influences NSCLC progression.
Main Methods
- Analysis of NUAK1 and NUAK2 mRNA expression in NSCLC tissues.
- Assessment of the impact of NUAK1/2 depletion or inhibition on NSCLC cell metabolism, proliferation, migration, and apoptosis.
- Investigation of the mechanistic link between NUAK1/2, p53, mTOR, and glucose metabolism.
Main Results
- NUAK1 and NUAK2 mRNA levels are elevated in NSCLC and correlate with poor prognosis.
- NUAK1/2 promotes aerobic glycolysis and PPP activity, enhancing NSCLC cell proliferation and migration.
- NUAK1/2 inhibition reduces these metabolic activities and tumor cell growth, inducing apoptosis.
- NUAK1/2 enhances mTOR signaling by suppressing p53, driving NSCLC progression.
Conclusions
- NUAK1/2 plays a critical role in the metabolic reprogramming and tumorigenesis of NSCLC.
- Targeting NUAK1/2 presents a potential therapeutic avenue for managing NSCLC metabolism and progression.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...